Wear it pink on 24 October Wear pink. Raise money. Help make life-changing breast cancer research and support happen.
Home About us Media Breast Cancer Now media statements 215 results We respond to new estimates that 57,215 people were living with secondary (metastatic) breast cancer in England in 2020 to 2021 22 Dec 2022 2 min read We respond to NICE’s approval of trastuzumab deruxtecan (Enhertu) for use on the Cancer Drugs Fund 20 Dec 2022 1 min read We respond to double SMC drug announcement - adjuvant abemaciclib and alpelisib with fulvestrant 12 Dec 2022 2 min read Pembrolizumab in combination with chemo is approved for use on the NHS in Scotland 10 Oct 2022 1 min read We respond to research about a potential new treatment for advanced breast cancer patients 08 Dec 2022 1 min read Breast Cancer Now responds to latest NHSE Cancer Wait Times data, calling for the FDS to be raised to 95% 13 Oct 2022 1 min read Fantastic outcome for certain patients with incurable secondary triple negative breast cancer as pembrolizumab (Keytruda) in combination with chemo (paclitaxel or nab-paclitaxel) is approved for use on the NHS in Scotland 10 Oct 2022 1 min read We welcome approval of palbociclib with fulvestrant for routine use on the NHS 23 Sept 2022 1 min read We respond to research about breast cancer surgery margins 22 Sept 2022 1 min read We respond to research about physical activity and breast cancer risk 07 Sept 2022 1 min read Breast Cancer Now responds to the HSJ and BBC Newsnight's joint special investigation about long cancer waits 11 Aug 2022 1 min read We respond to MP Dawn Butler's mission to find the Million Missing Mammograms 02 Aug 2022 1 min read Previous 1 ... 11 ... 18 Next
We respond to new estimates that 57,215 people were living with secondary (metastatic) breast cancer in England in 2020 to 2021 22 Dec 2022 2 min read
We respond to NICE’s approval of trastuzumab deruxtecan (Enhertu) for use on the Cancer Drugs Fund 20 Dec 2022 1 min read
We respond to double SMC drug announcement - adjuvant abemaciclib and alpelisib with fulvestrant 12 Dec 2022 2 min read
Pembrolizumab in combination with chemo is approved for use on the NHS in Scotland 10 Oct 2022 1 min read
We respond to research about a potential new treatment for advanced breast cancer patients 08 Dec 2022 1 min read
Breast Cancer Now responds to latest NHSE Cancer Wait Times data, calling for the FDS to be raised to 95% 13 Oct 2022 1 min read
Fantastic outcome for certain patients with incurable secondary triple negative breast cancer as pembrolizumab (Keytruda) in combination with chemo (paclitaxel or nab-paclitaxel) is approved for use on the NHS in Scotland 10 Oct 2022 1 min read
We welcome approval of palbociclib with fulvestrant for routine use on the NHS 23 Sept 2022 1 min read
Breast Cancer Now responds to the HSJ and BBC Newsnight's joint special investigation about long cancer waits 11 Aug 2022 1 min read
